Background
Studies of inpatient COVID-19 mortality risk factors have mainly used data from academic medical centers or large multi-hospital databases and have not examined populations with large proportions of Hispanic/Latino patients. In a retrospective cohort study of 4,881 consecutive adult COVID-19 hospitalizations at a single community hospital in Los Angeles County with a majority Hispanic/Latino population, we evaluated factors associated with mortality.
Methods
Data on demographic characteristics, comorbidities, laboratory and clinical results, and COVID-19 therapeutics were abstracted from the electronic medical record. Cox proportional hazards regression modelled statistically significantly independently associated predictors of hospital mortality.
Results
Age ≥ 65 years (HR = 2.66; 95% CI = 1.90, 3.72), male sex (HR = 1.31; 95% CI = 1.07, 1.60), renal disease (HR = 1.52; 95% CI = 1.18, 1.95), cardiovascular disease (HR = 1.45; 95% CI = 1.18, 1.78), neurological disease (HR = 1.84; 95% CI = 1.41, 2.39), D-dimer ≥ 500 ng/ml (HR = 2.07; 95% CI = 1.43, 3.0), and pulse oxygen level < 88% (HR = 1.39; 95% CI = 1.13, 1.71) were independently associated with increased mortality. Patient household with multiple COVID-19 cases, and Asian, Black, or Hispanic compared to White non-Hispanic race/ethnicity were associated with reduced mortality. In hypoxic COVID-19 inpatients, remdesivir, tocilizumab, and convalescent plasma were associated with reduced mortality, and corticosteroid use with increased mortality.
Conclusions
We corroborate several previously identified mortality risk factors and find evidence that the combination of factors associated with mortality differ between populations.